Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Biocon Ltd

NSE: BIOCON · BSE: 532523 · Pharmaceuticals & Biotechnology · 57 announcements

Biocon Ltd news stories on ALFA NewsRead the news →
Share price
₹360.70
Market cap
₹58,783 Cr
Revenue (annual)
₹16,927 Cr
Net profit (annual)
₹385.6 Cr
P/E (TTM)
118.7×Sector 47.4×
Promoter holding
44.68%-0.23% QoQ
FII holding
8.14%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

20:58 IST BSE
Other Announcement

Biocon Other Announcement

Biocon has initiated the remittance of the final dividend for FY 2025-26. This notification confirms the dispatch process for shareholders.

17:08 IST NSE
Other Announcement

Biocon Other Announcement

Biocon Ltd filed its Monitoring Agency Report for the quarter ended June 30, 2026, regarding the utilization of proceeds from its previous QIP.

12:03 IST BSE
Other Announcement

Biocon Other Announcement

Biocon Ltd filed its quarterly shareholding pattern as of June 30, 2026. The filing details holdings across promoter, institutional, and public categories.

20:44 IST NSE
Other Announcement

Biocon Other Announcement

Biocon Limited submitted a compliance certificate under SEBI Regulations for the quarter ended March 31, 2026. The certificate confirms that security certificates received for dematerialization were processed and mutilated by the Registrar, KFin Technologies Limited. This is a routine quarterly disclosure with no direct financial impact.